Laboratory controls do not include the establishment of scientifically sound and appropriate test procedures designed to assure that drug products conform to appropriate standards of identity, strength, quality and purity.
Inspection Record
Omrix Biopharmaceuticals Ltd. — FDA 483 Findings
Inspectors Mihaly S Ligmond · Steven E Bowen · Chava Kimchi SarfatyThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Established laboratory control mechanisms are not documented at the time ofperformance.
Batch production and control records do not include complete labeling control records, including specimens or copies of all labeling used for each batch of drug product produced.
Laboratory records are deficient in that they do not include a complete record of all data obtained during testing.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Nelson Laboratories, LLC2025-07-30 · US FDASimilar to finding 4 Laboratory records are deficient in that they do not include a complete record of all data obtained during testing.
- Neeyaan LLC2026-01-27 · US FDASimilar to finding 4 Laboratory records are deficient in that they do not include a complete record of all data obtained during testing.
- Torrent Pharmaceuticals Limited2017-04-28 · US FDASimilar to finding 1 Laboratory controls do not include the establishment ofscientifically sound and appropriate test procedures designed to assure that drug products conform to…
- Aurobindo Pharma Limited, Unit VII2026-02-10 · US FDASimilar to finding 4 Laboratory records are deficient in that they do not include a complete record ofall data obtained during testing.
- Pharmathen International S.A.2025-11-21 · US FDASimilar to finding 1 Laboratory controls do not include the establishment of scientifically sound and appropriate test procedures designed to assure that drug products conform to…
A record as of the US FDA document published on 2026-10-26. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.